Related Experiment Video
Updated: Jun 3, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization
Rebecca Feltham1, Bodhi Bettjeman, Rhesa Budhidarmo
1Department of Biochemistry, La Trobe University, Victoria 3086, Australia.
Abstract:
The inhibitor of apoptosis (IAP) proteins are important ubiquitin E3 ligases that regulate cell survival and oncogenesis. The cIAP1 and cIAP2 paralogs bear three N-terminal baculoviral IAP repeat (BIR) domains and a C-terminal E3 ligase RING domain. IAP antagonist compounds, also known as Smac mimetics, bind the BIR domains of IAPs and trigger rapid RING-dependent autoubiquitylation, but the mechanism is unknown. We show that RING dimerization is essential for the E3 ligase activity of cIAP1 and cIAP2 because monomeric RING mutants could not interact with the ubiquitin-charged E2 enzyme and were resistant to Smac mimetic-induced autoubiquitylation. Unexpectedly, the BIR domains inhibited cIAP1 RING dimerization, and cIAP1 existed predominantly as an inactive monomer. However, addition of either mono- or bivalent Smac mimetics relieved this inhibition, thereby allowing dimer formation and promoting E3 ligase activation. In contrast, the cIAP2 dimer was more stable, had higher intrinsic E3 ligase activity, and was not highly activated by Smac mimetics. These results explain how Smac mimetics promote rapid destruction of cIAP1 and suggest mechanisms for activating cIAP1 in other pathways.
Insights
Smac mimetics activate inhibitor of apoptosis (IAP) E3 ligases by promoting RING domain dimerization. This mechanism explains how Smac mimetics induce cIAP1 destruction and offers insights into IAP activation.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Inhibitor of apoptosis (IAP) proteins are crucial ubiquitin E3 ligases regulating cell survival and cancer.
- IAP antagonists (Smac mimetics) induce autoubiquitylation, but the underlying mechanism remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which Smac mimetics activate cIAP1 and cIAP2 E3 ligase activity.
- To investigate the role of RING domain dimerization and BIR domains in IAP regulation.
Main Methods:
- Utilized monomeric RING mutants to assess E3 ligase activity and E2 enzyme interaction.
- Investigated the effect of Smac mimetics on cIAP1 and cIAP2 dimerization and autoubiquitylation.
- Compared the activity and Smac mimetic response of cIAP1 and cIAP2.
Main Results:
- RING dimerization is essential for cIAP1 and cIAP2 E3 ligase activity.
- cIAP1's BIR domains inhibit RING dimerization, maintaining it as an inactive monomer.
- Smac mimetics relieve BIR-mediated inhibition, enabling cIAP1 RING dimerization and activation.
- cIAP2 exhibits a more stable dimer with higher intrinsic activity, showing less activation by Smac mimetics.
Conclusions:
- Smac mimetics activate cIAP1 by promoting RING dimerization, explaining its rapid destruction.
- The findings provide a mechanistic basis for Smac mimetic action and suggest pathways for cIAP1 activation.
Related Concept Videos
Anaphase Promoting Complex
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
IP3/DAG Signaling Pathway
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
